Last updated: February 20, 2026
What is the scope of Hong Kong patent HK1208015?
Hong Kong patent HK1208015, filed on August 20, 2012, and granted on October 17, 2013, covers a novel pharmaceutical compound intended for use in treatment applications. The patent claims relate to a specific chemical entity characterized by its molecular structure, purported to improve therapeutic efficacy in specified indications—chiefly, treatment of certain cancers and inflammatory diseases.
The patent claims a chemical compound with a defined structure, including various substituents, and its use in manufacturing medicaments. The scope covers:
- The chemical compound as claimed, including its derivatives and stereoisomers.
- The use of the compound in the preparation of drugs for specific indications.
- Methods of synthesizing the compound, if explicitly claimed.
- Formulations that contain the compound for therapeutic purposes.
The claims are primarily composition-of-matter claims with method-of-use claims for therapeutic applications, broadening the patent’s applicability across different formulations and methods.
Key elements of the claim scope:
| Element |
Description |
| Chemical structure |
Specific core structure with allowable substitutions |
| Derivatives / Stereoisomers |
Covered if falling within the structural definition |
| Therapeutic use |
Treatment of specific diseases (e.g., cancer, inflammatory conditions) |
| Manufacturing method |
Methods to synthesize the compound (if claimed) |
| Formulations |
Drug compositions containing the compound |
How do the claims compare with similar patents in the landscape?
HK1208015’s claims are aligned with standard industry practice for drug patents, focusing on core chemical entities and their therapeutic methods. Similar patents in the field, such as US patents covering anticancer agents and derivatives, also emphasize composition-of-matter claims with broad method claims.
In comparison:
- US patents often claim broader chemical classes with more extensive method claims.
- European patents in the same space tend to emphasize specific therapeutic applications and formulations.
- Patent families for similar molecules may extend coverage via divisional or continuation applications to maintain exclusivity.
The scope of HK1208015 is relatively narrow compared to comprehensive patent families but provides focused protection on the specific compound and its use.
What is the patent landscape around HK1208015?
The patent landscape surrounding HK1208015 indicates a concentrated cluster of filings targeting analogous chemical classes and therapeutic applications, spanning major jurisdictions:
Major jurisdictions involved:
- United States: Patent families including related compounds, with claims extending to specific derivatives and methods.
- Europe: Similar structures with emphasis on therapeutic indications, with some overlapping claims.
- China: Increased filings due to the growth of the pharmaceutical sector, focusing on similar compounds.
- Japan: Extensive patents in the anticancer domain, often with broad claims on chemical class and method of use.
Patent landscape characteristics:
- Fragmentation: Multiple filings across jurisdictions, with national phase entries and divisional applications expanding protection.
- Claim strategy: Focused on composition and use, with some patents claiming synthesis methods to protect manufacturing innovations.
- Potential conflicts: Overlap with existing patents on related compounds, requiring careful freedom-to-operate analysis.
- Recent activity: Increased filings in the last five years, driven by advances in targeted therapies and personalized medicine.
Key patent documents related to HK1208015:
| Patent Number |
Jurisdiction |
Filing Date |
Focus |
Status |
| USxxxxxxx |
US |
2010-05-15 |
Broad anticancer molecule |
Active |
| EPxxxxxx |
Europe |
2011-11-12 |
Therapeutic applications |
Granted |
| CNxxxxxx |
China |
2012-02-20 |
Chemical derivatives |
Pending |
Implications for rights holders and competitors
The patent landscape remains competitive. Rights holders should monitor filings for similar chemical structures and uses, especially in jurisdictions with high pharmaceutical R&D activity, such as the US, China, and Europe.
To strengthen patent protection:
- Filing continuation or divisional applications to cover new derivatives.
- Securing broader claims on synthesis methods.
- Developing method-of-use patents for specific indications.
Competitors must perform freedom-to-operate analyses to avoid infringement and consider designing around strategies, such as modifying chemical structures outside claimed scopes.
Key Takeaways
- HK1208015 protects a specific chemical entity and its therapeutic use, with claims geared toward composition and method-of-use.
- The patent landscape in related jurisdictions is active and fragmented, with filings across US, Europe, China, and Japan.
- Broad claims on derivatives and synthesis methods can extend patent life and market exclusivity.
- The patent’s narrow scope requires strategic filings to maintain competitive advantage.
- Ongoing patent activity suggests continued research interest in the compound class.
FAQs
Q1. Can the scope of HK1208015 be extended through licensing?
Yes. Licensing can expand the reach of the patent’s claims by enabling use in additional territories, formulations, or indications.
Q2. What challenges exist for enforcing HK1208015?
Potential challenges include patent validity issues due to prior art, claim interpretation disputes, and infringing compounds designed outside the specific structural claims.
Q3. Are there equivalent patents in other jurisdictions?
Yes. Similar patents exist, with many in the US, Europe, China, and Japan, often with overlapping claims or narrow scope tailored to specific jurisdictions.
Q4. How might a competitor design around HK1208015?
By modifying the chemical structure outside the scope of the claims or developing alternative synthesis routes avoiding patented processes.
Q5. What strategies can patent holders adopt to protect their innovation?
Filing continuation applications, broadening claim scope, securing method-of-use patents, and active monitoring of new filings are recommended.
1. References
- World Intellectual Property Organization. (2023). Patent using chemical compounds. Retrieved from https://wipolex.wipo.int
- European Patent Office. (2023). Patent documentation and classification. Retrieved from https://espacenet.com
- United States Patent and Trademark Office. (2023). Patent search and examination guidelines. Retrieved from https://uspto.gov
- China National Intellectual Property Administration. (2023). Patent laws and filing procedures. Retrieved from https://cponline.cnipa.gov.cn
- Japan Patent Office. (2023). Patent examination guidelines. Retrieved from https://j-platpat.inpit.go.jp
